A non-randomized controlled trial to assess the protective effect of SMC in the context of high parasite resistance in Uganda

BACKGROUND: Until recently, due to widespread prevalence of molecular markers associated with sulfadoxine-pyrimethamine (SP) and amodiaquine (AQ) resistance in east and southern Africa, seasonal malaria chemoprevention (SMC) has not been used at scale in this region. This study assessed the protecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Nuwa, Anthony, Baker, Kevin, Bonnington, Craig, Odongo, Musa, Kyagulanyi, Tonny, Bwanika, John Baptist, Richardson, Sol, Nabakooza, Jane, Achan, Jane, Kajubi, Richard, Odong, David Salandini, Nakirunda, Maureen, Magumba, Godfrey, Beinomugisha, Geofrey, Marasciulo-Rice, Madeleine, Abio, Hilda, Rassi, Christian, Rutazaana, Damian, Rubahika, Denis, Tibenderana, James, Opigo, Jimmy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945593/
https://www.ncbi.nlm.nih.gov/pubmed/36814301
http://dx.doi.org/10.1186/s12936-023-04488-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945593/
https://www.ncbi.nlm.nih.gov/pubmed/36814301
http://dx.doi.org/10.1186/s12936-023-04488-4

Ejemplares similares